Matias B Yudi1, Jay Ramchand1, Omar Farouque1, Nick Andrianopoulos2, William Chan3, Stephen J Duffy4, Jeffrey Lefkovits5, Angela Brennan2, Ryan Spencer6, Dharsh Fernando6, Chin Hiew7, Melanie Freeman8, Christopher M Reid9, Andrew E Ajani10, David J Clark11. 1. Department of Cardiology, Austin Health, Melbourne, Australia; University of Melbourne, Melbourne, Australia. 2. Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Australia. 3. Department of Cardiology, Alfred Hospital, Melbourne, Australia. 4. Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Australia; Department of Cardiology, Alfred Hospital, Melbourne, Australia. 5. Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia. 6. Department of Cardiology, Austin Health, Melbourne, Australia. 7. Department of Cardiology, Geelong Hospital, Geelong, Australia. 8. Department of Cardiology, Box Hill Hospital, Melbourne, Australia. 9. Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Australia; School of Public Health, Curtin University, Perth, Western Australia, Australia. 10. University of Melbourne, Melbourne, Australia; Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Australia; Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia. 11. Department of Cardiology, Austin Health, Melbourne, Australia; University of Melbourne, Melbourne, Australia. Electronic address: david.clark@austin.org.au.
Abstract
BACKGROUND: Door-to-balloon time (DTBT) less than 90min remains the benchmark of timely reperfusion in ST-elevation myocardial infarction (STEMI). The relative long-term benefit of timely reperfusion in STEMI patients with differing risk profiles is less certain. Thus, we aimed to assess the impact of DTBT on long-term mortality in high- and low-risk STEMI patients. METHOD: We analysed baseline clinical and procedural characteristics of 2539 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) from the Melbourne Interventional Group registry from 2004 to 2012. Patients were classified high risk (HR-STEMI) if they presented with cardiogenic shock, out-of-hospital cardiac arrest (OHCA) or Killip class ≥2; or low-risk (LR-STEMI) if there were no high-risk features. We then stratified high- and low-risk patients by DTBT (≤90min vs. >90min) and assessed long-term mortality. RESULT: Of the 2539 patients, 395 (16%) met the high-risk criteria. A DTBT ≤90min was achieved in 43% of HR-STEMI patients and in 55% of LR-STEMI patients. Patients in the HR-STEMI compared to LR-STEMI cohort had higher in-hospital (31% vs. 1%, p<0.01) and long-term mortality (37% vs. 7%, p<0.01). A DTBT ≤90min was associated with significant improvements in short- and long-term mortality in both groups. A DTBT ≤90min was an independent multivariate predictor of long-term survival in LR-STEMI (hazard ratio [HR] 0.5, 95% confidence interval [CI] 0.3-0.9, p=0.02) but not in HR-STEMI (HR 0.7, 95% CI 0.5-1.1, p=0.11). CONCLUSION: A DTBT ≤90min was associated with improved short- and long-term outcomes in high- and low-risk STEMI patients. However, it was only an independent predictor of long-term survival in LR-STEMI patients.
BACKGROUND: Door-to-balloon time (DTBT) less than 90min remains the benchmark of timely reperfusion in ST-elevation myocardial infarction (STEMI). The relative long-term benefit of timely reperfusion in STEMI patients with differing risk profiles is less certain. Thus, we aimed to assess the impact of DTBT on long-term mortality in high- and low-risk STEMI patients. METHOD: We analysed baseline clinical and procedural characteristics of 2539 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) from the Melbourne Interventional Group registry from 2004 to 2012. Patients were classified high risk (HR-STEMI) if they presented with cardiogenic shock, out-of-hospital cardiac arrest (OHCA) or Killip class ≥2; or low-risk (LR-STEMI) if there were no high-risk features. We then stratified high- and low-risk patients by DTBT (≤90min vs. >90min) and assessed long-term mortality. RESULT: Of the 2539 patients, 395 (16%) met the high-risk criteria. A DTBT ≤90min was achieved in 43% of HR-STEMI patients and in 55% of LR-STEMI patients. Patients in the HR-STEMI compared to LR-STEMI cohort had higher in-hospital (31% vs. 1%, p<0.01) and long-term mortality (37% vs. 7%, p<0.01). A DTBT ≤90min was associated with significant improvements in short- and long-term mortality in both groups. A DTBT ≤90min was an independent multivariate predictor of long-term survival in LR-STEMI (hazard ratio [HR] 0.5, 95% confidence interval [CI] 0.3-0.9, p=0.02) but not in HR-STEMI (HR 0.7, 95% CI 0.5-1.1, p=0.11). CONCLUSION: A DTBT ≤90min was associated with improved short- and long-term outcomes in high- and low-risk STEMI patients. However, it was only an independent predictor of long-term survival in LR-STEMI patients.
Authors: Billy A Caceres; Meghan Reading Turchioe; Anthony Pho; Theresa A Koleck; Ruth Masterson Creber; Suzanne B Bakken Journal: Am J Health Promot Date: 2020-06-19
Authors: Mitchell N Sarkies; Suzanne Robinson; Tom Briffa; Stephen J Duffy; Mark Nelson; John Beltrame; Louise Cullen; Derek Chew; Julian Smith; David Brieger; Peter Macdonald; Danny Liew; Chris Reid Journal: Health Res Policy Syst Date: 2021-04-21
Authors: Yu Ri Kim; Myung Ho Jeong; Min Jeong An; Xiongyi Han; Kyung Hoon Cho; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn Journal: Yonsei Med J Date: 2022-02 Impact factor: 2.759
Authors: Chee Yoong Foo; Nick Andrianopoulos; Angela Brennan; Andrew Ajani; Christopher M Reid; Stephen J Duffy; David J Clark; Daniel D Reidpath; Nathorn Chaiyakunapruk Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379
Authors: Peter Lee; Angela L Brennan; Dion Stub; Diem T Dinh; Jeffrey Lefkovits; Christopher M Reid; Ella Zomer; Danny Liew Journal: BMJ Open Date: 2021-12-07 Impact factor: 2.692